Subject
Pulmonary and Respiratory Medicine
Reference9 articles.
1. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials;Castro;Lancet Respir Med,2015
2. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study;Castro;Lancet Respir Med,2014
3. Mepolizumab treatment in patients with severe eosinophilic asthma;Ortega;N Engl J Med,2014
4. Effect of SCH55700, a humanized anti-human interleukin-5 antibody in severe persistent asthma: a pilot study;Kips;Am J Resp Crit Care Med,2003
5. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma;Flood-Page;Am J Respir Crit Care Med,2007
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献